Analyst Price Target is $65.17
▲ +93.37% Upside Potential
This price target is based on 9 analysts offering 12 month price targets for Astrana Health in the last 3 months. The average price target is $65.17, with a high forecast of $86.00 and a low forecast of $50.00. The average price target represents a 93.37% upside from the last price of $33.70.
Current Consensus is
Moderate Buy
The current consensus among 9 investment analysts is to moderate buy stock in Astrana Health. This rating changed within the last month from a Buy consensus rating.
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
Read More
